S&P 500   4,235.19 (-1.24%)
DOW   33,069.34 (-1.09%)
QQQ   355.90 (-1.48%)
AAPL   172.54 (-0.70%)
MSFT   313.70 (-2.52%)
META   301.25 (-1.82%)
GOOGL   132.94 (-0.92%)
AMZN   125.30 (-3.21%)
TSLA   248.58 (-1.20%)
NVDA   440.23 (-1.69%)
NIO   8.72 (-0.80%)
BABA   84.80 (-2.00%)
AMD   100.96 (-2.24%)
T   14.61 (-0.41%)
F   12.11 (-1.62%)
MU   68.61 (+0.96%)
CGC   0.70 (-4.99%)
GE   107.83 (-0.88%)
DIS   79.92 (-2.14%)
AMC   8.05 (-1.23%)
PFE   33.91 (-0.09%)
PYPL   57.71 (-1.45%)
NFLX   379.30 (-0.27%)
S&P 500   4,235.19 (-1.24%)
DOW   33,069.34 (-1.09%)
QQQ   355.90 (-1.48%)
AAPL   172.54 (-0.70%)
MSFT   313.70 (-2.52%)
META   301.25 (-1.82%)
GOOGL   132.94 (-0.92%)
AMZN   125.30 (-3.21%)
TSLA   248.58 (-1.20%)
NVDA   440.23 (-1.69%)
NIO   8.72 (-0.80%)
BABA   84.80 (-2.00%)
AMD   100.96 (-2.24%)
T   14.61 (-0.41%)
F   12.11 (-1.62%)
MU   68.61 (+0.96%)
CGC   0.70 (-4.99%)
GE   107.83 (-0.88%)
DIS   79.92 (-2.14%)
AMC   8.05 (-1.23%)
PFE   33.91 (-0.09%)
PYPL   57.71 (-1.45%)
NFLX   379.30 (-0.27%)
S&P 500   4,235.19 (-1.24%)
DOW   33,069.34 (-1.09%)
QQQ   355.90 (-1.48%)
AAPL   172.54 (-0.70%)
MSFT   313.70 (-2.52%)
META   301.25 (-1.82%)
GOOGL   132.94 (-0.92%)
AMZN   125.30 (-3.21%)
TSLA   248.58 (-1.20%)
NVDA   440.23 (-1.69%)
NIO   8.72 (-0.80%)
BABA   84.80 (-2.00%)
AMD   100.96 (-2.24%)
T   14.61 (-0.41%)
F   12.11 (-1.62%)
MU   68.61 (+0.96%)
CGC   0.70 (-4.99%)
GE   107.83 (-0.88%)
DIS   79.92 (-2.14%)
AMC   8.05 (-1.23%)
PFE   33.91 (-0.09%)
PYPL   57.71 (-1.45%)
NFLX   379.30 (-0.27%)
S&P 500   4,235.19 (-1.24%)
DOW   33,069.34 (-1.09%)
QQQ   355.90 (-1.48%)
AAPL   172.54 (-0.70%)
MSFT   313.70 (-2.52%)
META   301.25 (-1.82%)
GOOGL   132.94 (-0.92%)
AMZN   125.30 (-3.21%)
TSLA   248.58 (-1.20%)
NVDA   440.23 (-1.69%)
NIO   8.72 (-0.80%)
BABA   84.80 (-2.00%)
AMD   100.96 (-2.24%)
T   14.61 (-0.41%)
F   12.11 (-1.62%)
MU   68.61 (+0.96%)
CGC   0.70 (-4.99%)
GE   107.83 (-0.88%)
DIS   79.92 (-2.14%)
AMC   8.05 (-1.23%)
PFE   33.91 (-0.09%)
PYPL   57.71 (-1.45%)
NFLX   379.30 (-0.27%)
CVE:ADK

DIAGNOS (ADK) Stock Forecast, Price & News

C$0.54
+0.01 (+0.94%)
(As of 11:57 AM ET)
Compare
Today's Range
C$0.52
C$0.54
50-Day Range
C$0.43
C$0.58
52-Week Range
C$0.15
C$0.59
Volume
35,500 shs
Average Volume
116,624 shs
Market Capitalization
C$38.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADK stock logo

About DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

ADK Price History

ADK Stock News Headlines

Diagnos, Appulse, Bedford at 52-Week Highs
Closing Bell: Diagnos Inc down on Friday (ADK)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Echelon Wealth Partners Believes Diagnos (ADK) Won’t Stop Here
TMX, Arrow, CPKC at 52-Week Highs on News
Closing Bell: Diagnos Inc up on Wednesday (ADK)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Closing Bell: Diagnos Inc up on Monday (ADK)
Closing Bell: Diagnos Inc up on Thursday (ADK)
Closing Bell: Diagnos Inc up on Tuesday (ADK)
DIAGNOS Successfully Completes ISO / MDSAP Audit
See More Headlines
Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Company Calendar

Last Earnings
8/24/2023
Today
10/03/2023
Next Earnings (Estimated)
12/05/2023

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-2,520,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$577,486.00
Cash Flow
C$0.01 per share
Book Value
C($0.03) per share

Miscellaneous

Free Float
N/A
Market Cap
C$37.95 million
Optionable
Not Optionable
Beta
-0.07
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Andre Larente
    CEO, Pres & Exec. Director
  • Mr. Marc-André Massue
    VP of Fin., CFO & Sec.
  • Mr. Martin Beland
    Director of Marketing













ADK Stock - Frequently Asked Questions

How have ADK shares performed in 2023?

DIAGNOS's stock was trading at C$0.28 at the beginning of the year. Since then, ADK stock has increased by 89.3% and is now trading at C$0.53.
View the best growth stocks for 2023 here
.

When is DIAGNOS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023.
View our ADK earnings forecast
.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (CVE:ADK) posted its earnings results on Thursday, August, 24th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $0.04 million during the quarter, compared to analysts' expectations of $0.10 million.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?

DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of ADK stock can currently be purchased for approximately C$0.53.

How much money does DIAGNOS make?

DIAGNOS (CVE:ADK) has a market capitalization of C$37.95 million and generates C$577,486.00 in revenue each year. The company earns C$-2,520,000.00 in net income (profit) each year or C($0.04) on an earnings per share basis.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882.

This page (CVE:ADK) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -